Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Ashish Manne, Edward Woods, Allan Tsung, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Current epidemiology of cholangiocarcinoma in Western countries
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 102
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 15
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
Edward Woods, Dat Tan Le, Bharath Kumar Jakka, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2137-2137
Open Access | Times Cited: 24
Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real‐world study
Alessandro Ottaiano, Mariachiara Santorsola, Anna Diana, et al.
Cancer Medicine (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 4
Biliary tract cancers: a descriptive study in the population treated at the Centre Hospitalier Universitaire de Sherbrooke (CHUS) between 2009 and 2021
Belinda Jiao, Mandy Malick, Samuel Lemaire‐Paquette, et al.
Academia oncology. (2025) Vol. 2, Iss. 1
Closed Access
Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers
Ruyin Chen, Dandan Zheng, Qiong Li, et al.
Cancer Letters (2022) Vol. 546, pp. 215853-215853
Closed Access | Times Cited: 21
Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
Woo Jin Choi, Tommy Ivanics, Annabel Gravely, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3849-3863
Closed Access | Times Cited: 11
Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
Marcello Moro Queiroz, Nildevande Firmino Lima, Tiago Biachi De Castria
Cancers (2023) Vol. 15, Iss. 7, pp. 1970-1970
Open Access | Times Cited: 11
Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
Maurizio Capuozzo, Mariachiara Santorsola, Loris Landi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15124-15124
Open Access | Times Cited: 16
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Bile liquid biopsy in biliary tract cancer
Fusheng Liu, Xingyuan Hao, Bin Liu, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117593-117593
Open Access | Times Cited: 9
Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma
Joanna Jiang, Dayssy A. Diaz, Surya Pratik Nuguru, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 50-50
Open Access | Times Cited: 15
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma
Changhoon Yoo, Jaewon Hyung, Stephen L. Chan
Liver Cancer (2023) Vol. 13, Iss. 2, pp. 119-135
Open Access | Times Cited: 8
Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies
Josepmaria Argemí, Mariano Ponz‐Sarvisé, Bruno Sangro
Advances in cancer research (2022), pp. 367-413
Closed Access | Times Cited: 13
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Öykü Gönül Geyik, Giulia Anichini, Engı̇n Ulukaya, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1463-1463
Open Access | Times Cited: 11
Precision Medicine in Cholangiocarcinoma: Past, Present, and Future
Chi-Yuan Cheng, Chiao‐Ping Chen, Chiao‐En Wu
Life (2022) Vol. 12, Iss. 6, pp. 829-829
Open Access | Times Cited: 11
mRNA vaccine development for cholangiocarcinoma: a precise pipeline
Tianyu Tang, Xing Huang, Gang Zhang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Bruno Almeida Costa, Paulino Tallón de Lara, Wungki Park, et al.
Oncology Research and Treatment (2023) Vol. 46, Iss. 5, pp. 211-215
Closed Access | Times Cited: 5
Changing Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010–2018
Florian Hucke, Matthias Pinter, Miriam Hucke, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 8
Perioperative and palliative systemic treatments for biliary tract cancer
Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
I. V. Savchenko, И. С. Стилиди, I. А. Dzhanyan, et al.
Journal of Modern Oncology (2024) Vol. 26, Iss. 2, pp. 202-209
Open Access | Times Cited: 1
[18F]FDG PET/CT in Benign and Malignant Diseases Involving the Biliary Tract
Meghana Prabhu, Fahad Nisamudeen, H Vikas
Indian Journal of Nuclear Medicine (2024) Vol. 39, Iss. 3, pp. 185-190
Open Access | Times Cited: 1
Targeted Therapy with Polymeric Nanoparticles in PBRM1-Mutant Biliary Tract Cancers: Harnessing DNA Damage Repair Mechanisms
Hrushikesh Wagh, Sankha Bhattacharya
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104505-104505
Closed Access | Times Cited: 1
Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14231-14231
Open Access | Times Cited: 2
Computational Analysis of Gastric Canceromics Data to Identify Putative Biomarkers
Sagarika Saha, Renu Vyas
Current Topics in Medicinal Chemistry (2023) Vol. 24, Iss. 2, pp. 128-156
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top